TXG
NASDAQ
$43.22
10x Genomics Inc - Class A (TXG)
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.
Sector:
Healthcare
Industry:
Health Information Services
Buy
Target: $39.85 (-7.80%)
Market Cap
$5.87B
Free Cash Flow Yield
2.08%
Beta (5Y)
2.04
Price Chart
Valuation
Market Cap$5.87B
Forward P/E714.29
P/S9.09
P/B7.14
Profitability
Total Revenue (TTM)$639M
Gross Profit (TTM)$445M
EBITDA-$569K
Profit Margin-8.9%
Operating Margin-11.3%
EPS-$0.33
Financial Health
Free Cash Flow Yield2.08%
Growth & Risk
Revenue 5Y CAGR+13.93%
Beta (5Y)2.04
Sharpe Ratio2.06